{
  "id": "PK_CYP2D6_INHIB_TRAMADOL",
  "name": "CYP2D6 inhibition can alter tramadol effect and tolerability",
  "domain": "PK",
  "severity": "major",
  "rule_class": "adjust_monitor",
  "tags": ["exposure_change", "activation_change"],
  "scenario": {
    "classification": "reference",
    "index_drug": "tramadol",
    "confidence": "medium",
    "notes": "Reference scenario: CYP2D6 inhibitor with tramadol (CYP2D6 involvement)."
  },
  "actions": [
    "Monitor for reduced analgesic response and/or increased adverse effects depending on patient-specific factors (educational).",
    "Consider alternatives if clinically appropriate."
  ],
  "logic": {
    "enzyme": {
      "id": "CYP2D6",
      "A_role": "substrate",
      "B_role": "inhibitor"
    },
    "A_name_is": "tramadol",
    "rationale": [
      "{B_name} inhibits CYP2D6.",
      "CYP2D6 contributes to tramadol metabolism and active metabolite formation.",
      "Inhibition may change tramadol response and tolerability."
    ]
  },
  "explanation_template": "{B_name} inhibits CYP2D6 and tramadol has CYP2D6-dependent metabolism. This may alter tramadol response (including reduced activation) and change adverse effect risk.",
  "references": [
    {
      "source": "Educational note",
      "citation": "CYP2D6 inhibition can meaningfully affect drugs with CYP2D6-dependent clearance or activation; tramadol is commonly cited in teaching examples."
    }
  ]
}
